Search

everythinglearnresearchcommunity

for

Search:↓

Combination of minoxidil and finasteride is more effective in increasing hair diameter than minoxidil alone for female-pattern hair loss.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Too much androgen can cause hair loss; finasteride may help.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

New treatments for male hypogonadism are effective and should be personalized.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Certain drugs that block specific enzymes can help treat prostate diseases.

Finasteride increases hair density in female androgenetic alopecia, but individual results may vary.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Hair regrowth slows with age and can be affected by treatments that change enzyme activity in the skin.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Hair aging and loss are caused by genetics, hormones, environment, and grooming, with treatments like minoxidil effective for certain types of hair loss.

Researchers created a cell line to study hair growth and found specific genes affected by dihydrotestosterone.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Finasteride may cause kidney damage.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Finasteride may improve stem cell therapy for heart attacks by increasing cell survival.

Hormones cause hair loss by affecting cell growth and weakening cell attraction.

Germacrene analogs, especially 8-Hydroxy germacrene B, are more effective than germacrone at blocking a hormone-related enzyme and could help treat hair loss.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.